Synthesis and anticonvulsant activity of novel and potent 2,3-benzodiazepine AMPA/kainate receptor antagonists.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Medicinal Chemistry

• Publication date

  1999-10-21

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM991086DPMID 10543885
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• 7,8-Methylenedioxy-4H-2,3-benzodiazepin-4-ones as novel AMPA receptor antagonists.

  1998cited by this paper
• 3,5-Dihydro-4H-2,3-benzodiazepine-4-thiones: a new class of AMPA receptor antagonists.

  1998cited by this paper
• 1-Aryl-3,5-dihydro-4H-2,3-benzodiazepin-4-ones: novel AMPA receptor antagonists.

  1997cited by this paper
• Substituted 1,2-dihydrophthalazines: potent, selective, and noncompetitive inhibitors of the AMPA receptor.

  1996cited by this paper
• GYKI 52466 and related 2,3-benzodiazepines as anticonvulsant agents in DBA/2 mice.

  1995cited by this paper
• Interactions among GYKI-52466, cyclothiazide, and aniracetam at recombinant AMPA and kainate receptors.

  1995cited by this paper
• Selective antagonism of AMPA receptors unmasks kainate receptor-mediated responses in hippocampal neurons.

  1995cited by this paper
• Non-N-methyl-D-aspartate receptor antagonism by 3-N-substituted 2,3-benzodiazepines: relationship to anticonvulsant activity.

  1994cited by this paper
• Effect of the Non‐NMDA Receptor Antagonist GYKI 52466 on the Microdialysate and Tissue Concentrations of Amino Acids Following Transient Forebrain Ischaemia

  1994cited by this paper
• Excitatory amino acid neurotransmission through both NMDA and non-NMDA receptors is involved in the anticonvulsant activity of felbamate in DBA/2 mice.

  1994cited by this paper
• A synaptic model of memory: long-term potentiation in the hippocampus

  1993cited by this paper
• Therapeutic potential of excitatory amino acid antagonists: channel blockers and 2,3-benzodiazepines.

  1993cited by this paper
• Cerebroprotective Effect of a Non–N‐Methyl‐D‐Aspartate Antagonist, GYKI 52466, After Focal Ischemia in the Rat

  1992cited by this paper
• The non-N-methyl-D-aspartate receptor antagonists, GYKI 52466 and NBQX are anticonvulsant in two animal models of reflex epilepsy.

  1991cited by this paper
• The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice.

  1991cited by this paper
• Allosteric potentiation of quisqualate receptors by a nootropic drug aniracetam.

  1990cited by this paper
• Excitatory and inhibitory amino acids and peptide-induced responses in acutely isolated rat spinal dorsal horn neurons.

  1989cited by this paper
• Lipophilicity measurement of benzodiazepine-receptor ligands by reversed-phase liquid chromatography. Comparison between high-performance liquid and thin-layer chromatography.

  1988cited by this paper
• Seizure Susceptibility in DBA and C57 Mice: The Effects of Various Convulsants

  1988cited by this paper
• Evaluation of anticonvulsant drugs in DBA/2 mice with sound-induced seizures.

  1984cited by this paper
• Selective release of glutamate from cerebellar granule cells differentiating in culture.

  1982cited by this paper
• A note on a simple apparatus for detecting neurological deficit in rats and mice.

  1957cited by this paper
• Comparative assays of antiepileptic drugs in mice and rats.

  1952cited by this paper
• A simplified method of evaluating dose-effect experiments.

  1948cited by this paper

• A simple route to 2,3-benzodiazepines from substituted indenes.

  2025cites this paper
• A Benzodiazepine-Derived Molecule That Interferes with the Bio-Mechanical Properties of Glioblastoma-Astrocytoma Cells Altering Their Proliferation and Migration

  2025cites this paper
• Synthesis, biological profile and computational insights of new derivatives of benzo [B][1,4] diazepines as prospective anticancer agents for inhibiting the CDK-2 protein

  2024cites this paper
• A Study on Biologically Active Chalcone Based Benzodiazepines

  2023cites this paper
• A Proteomic Platform Unveils the Brain Glycogen Phosphorylase as a Potential Therapeutic Target for Glioblastoma Multiforme

  2022cites this paper
• A Study on Synthesis of Benzodiazepine Scaffolds using Biologically Active Chalcones as Precursors

  2022cites this paper
• Study on the cycloaddition reactions of pyrrolotriazepine derivatives with nitrile oxides. Synthesis of new fused tricyclic ring systems

  2017cites this paper
• Development of novel N-3-bromoisoxazolin-5-yl substituted 2,3-benzodiazepines as noncompetitive AMPAR antagonists.

  2017cites this paper
• Synthesis of new tricyclic imidazotriazepine derivatives condensed with various heterocycles

  2017cites this paper
• Synthesis of 2,3-Benzodiazepines via Rh(III)-Catalyzed C-H Functionalization of N-Boc Hydrazones with Diazoketoesters.

  2017cites this paper
• A novel 2,3-benzodiazepine-4-one derivative AMPA antagonist inhibits G2/M transition and induces apoptosis in human leukemia Jurkat T cell line.

  2016cites this paper
• Efficient synthesis of a new compound family, 9-aryl-5H-imidazo[2,1-d][1,2,5]triazepin-6(7H)-ones

  2016cites this paper
• Structural Bases of Noncompetitive Inhibition of AMPA-Subtype Ionotropic Glutamate Receptors by Antiepileptic Drugs.

  2016cites this paper
• Evaluation of Anxiolytic, Sedative-hypnotic and Amnesic Effects of Novel 2-phenoxy phenyl-1,3,4-oxadizole Derivatives Using Experimental Models

  2015cites this paper
• Mechanism-based design of 2,3-benzodiazepine inhibitors for AMPA receptors

  2015cites this paper
• Mechanism and site of inhibition of AMPA receptors: pairing a thiadiazole with a 2,3-benzodiazepine scaffold.

  2014cites this paper
• Structure activity relationships of novel antiepileptic drugs.

  2014cites this paper
• Synthesis of a new compound family, 1-aryl-3H-pyrrolo[2,1-d][1,2,5]triazepin-4(5H)-ones

  2014cites this paper
• Mechanism of inhibition of the GluA2 AMPA receptor channel opening by talampanel and its enantiomer: the stereochemistry of the 4-methyl group on the diazepine ring of 2,3-benzodiazepine derivatives.

  2013cites this paper
• ON ANTICONVULSANT ACTIVITY OF 1 , 3-BENZODIOXOLE RING SYSTEM BASED COMPOUNDS

  2013cites this paper
• A REVIEW ON ANTICONVULSANT ACTIVITY OF 1, 3-BENZODIOXOLE RING SYSTEM BASED COMPOUNDS

  2013cites this paper
• Synthesis and Evaluation of Anticonvulsant Activity of 6,8-Dimethoxy-3-methyl-1,2,3,4-tetrahydroisoquinoline in PTZ-Induced Seizure Model in Mice

  2012cites this paper
• alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid (AMPA) antagonists: from bench to bedside.

  2010cites this paper
• A series of structurally novel heterotricyclic α‐amino‐3‐hydroxyl‐5‐methyl‐4‐isoxazole‐propionate receptor‐selective antagonists

  2010cites this paper
• Structure-activity study of 2,3-benzodiazepin-4-ones noncompetitive AMPAR antagonists: identification of the 1-(4-amino-3-methylphenyl)-3,5-dihydro-7,8-ethylenedioxy-4H-2,3-benzodiazepin-4-one as neuroprotective agent.

  2008cites this paper
• Synthesis of some indole based spiro and condensed heterocycles as potential biologically active agents

  2008cites this paper
• Antagonists of AMPA/KA and NMDA (glycine site) glutamate receptors

  2008cites this paper
• Neuroprotective and anticonvulsant effects of EGIS‐8332, a non‐competitive AMPA receptor antagonist, in a range of animal models

  2007cites this paper
• Synthesis of Novel 3‐(Alkylcarbamoyl)‐2‐aryl‐1,2‐dihydro‐6,7‐(methylenedioxy)‐3H‐quinazolin‐4‐ones as Anticonvulsant Agents

  2006cites this paper
• New 7,8-ethylenedioxy-2,3-benzodiazepines as noncompetitive AMPA receptor antagonists.

  2006cites this paper
• Novel alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate (AMPA) receptor antagonists of 2,3-benzodiazepine type: chemical synthesis, in vitro characterization, and in vivo prevention of acute neurodegeneration.

  2005cites this paper
• Structural Features of the Binding Site for Diphenin and other Anticonvulsants belonging to the Group of Sodium Channel Blockers

  2005cites this paper
• AMPA receptor antagonists as potential anticonvulsant drugs.

  2005cites this paper
• Synthesis of 2-semicarbazonomethyl-4,5-methylenedioxyphenylacetic acids as anticonvulsant agents.

  2005cites this paper
• New features in synthesis of talampanel related 2,3-benzodiazepines.

  2005cites this paper
• QSAR study of anticonvulsant negative allosteric modulators of the AMPA receptor.

  2004cites this paper
• Design of 1-substituted 2-arylmethyl-4,5-methylenedioxybenzene derivatives as antiseizure agents.

  2004cites this paper
• Pharmacology and prospective therapeutic usefulness of negative allosteric modulators of AMPA receptors

  2004cites this paper
• Design and synthesis of 4H-3-(2-phenoxy)phenyl-1,2,4-triazole derivatives as benzodiazepine receptor agonists.

  2003cites this paper
• Characterization of the mechanism of anticonvulsant activity for a selected set of putative AMPA receptor antagonists.

  2003cites this paper
• 1-aryl-6,7-methylenedioxy-3H-quinazolin-4-ones as anticonvulsant agents.

  2003cites this paper
• 5-phenyl-9H-1,3-dioxolo[4,5-h][2,3]benzodiazepin-8(7H)-one.

  2003cites this paper
• One-pot synthesis of 2,4-benzodiazepin-1-ones using benzotriazole methodology.

  2002cites this paper
• Non-competitive AMPA antagonists of 2,3-benzodiazepine type.

  2002cites this paper
• Excitatory amino acids.

  2002cites this paper
• A SIMPLE AND EFFICIENT SYNTHESIS OF GYKI 52466 AND GYKI 52895

  2002cites this paper
• Synthesis and spectral properties of 2‐methylthio‐3H‐7‐[(o‐; m‐ and p‐substituted)phenoxy]‐4‐(p‐substituted‐phenyl)‐[1,5]benzodiazepines

  2002cites this paper
• Chromatographic determination of 7,8-methylenedioxy-4H-2,3-benzodiazepin-4-ones in rat plasma: relationship to their anticonvulsant activity.

  2002cites this paper
• Novel potent AMPA/kainate receptor antagonists: synthesis and anticonvulsant activity of a series of 2-[(4-alkylsemicarbazono)-(4-amino-phenyl)methyl]-4,5-methylenedioxyphenylacetic acid alkyl esters.

  2002cites this paper
• Synthesis and structure-activity relationships of 2,3-benzodiazepines as AMPA receptor antagonists.

  2001cites this paper
• Synthesis and anticonvulsant activity of novel and potent 1-aryl-7,8-methylenedioxy-1,2,3,5-tetrahydro-4H-2,3-benzodiazepin-4-ones.

  2001cites this paper
• Synthesis and evaluation of pharmacological and pharmacokinetic properties of 11H-[1,2,4]triazolo[4,5-c][2,3]benzodiazepin-3(2H)-ones.

  2000cites this paper
• Synthesis and anticonvulsant activity of 4-bromophenyl substituted aryl semicarbazones.

  2000cites this paper
• Structural analogues of some highly active non-competitive AMPA antagonists.

  2000cites this paper
• Synthesis and anticonvulsant activity of novel and potent 6,7-methylenedioxyphthalazin-1(2H)-ones.

  2000cites this paper
• New non competitive AMPA antagonists.

  2000cites this paper
• Excitatory amino acids.

  1998cites this paper